<DOC>
	<DOCNO>NCT00841776</DOCNO>
	<brief_summary>The purpose study determine development microbial resistance use one two topical acne therapy treatment facial acne vulgaris .</brief_summary>
	<brief_title>Comparative Antimicrobial Efficacy Two Topical Acne Therapies Treatment Facial Acne</brief_title>
	<detailed_description>To investigate development microbial resistance use one two topical acne therapy treatment moderate moderately severe facial acne vulgaris . Clinical efficacy tolerability assess .</detailed_description>
	<mesh_term>Acne Vulgaris</mesh_term>
	<mesh_term>Clindamycin</mesh_term>
	<mesh_term>Anti-Infective Agents</mesh_term>
	<mesh_term>Benzoyl Peroxide</mesh_term>
	<criteria>Outpatient least 12 year age . Female subject childbearing potential must negative urine pregnancy test result baseline practice reliable method contraception throughout study . Mild moderate facial acne vulgaris Able understand requirement study sign inform consent/HIPAA authorization form . Subjects legal age consent state study conduct must also write , informed consent parent legal guardian . Female subject pregnant ( positive urine pregnancy test ) , breast feed childbearing potential practicing reliable method birth control Allergy sensitivity component test medication Known hypersensitivity component investigational formulation Known history enteritis ( regional enteritis , ulcerative colitis , pseudomembranous colitis , antibioticassociated colitis Beards sideburns Skin disease/disorder might interfere diagnosis evaluation acne vulgaris Evidence recent alcohol drug abuse Participation investigational drug study within 30 day baseline visit</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2011</verification_date>
	<keyword>Acne Vulgaris</keyword>
	<keyword>Acne</keyword>
</DOC>